B-cell activating factor and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) influence progression of chronic lymphocytic leukemia

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 44, 2010, Pages 18956-18960

  Zhang, Weizhou ^a   Kater, Arnon P ^b   Widhopf II, George F ^a   Chuang, Han Yu ^a   Enzler, Thomas ^c   James, Danelle F ^a   Poustovoitov, Maxim ^a   Tseng, Ping Hui ^d   Janz, Siegfried ^e   Hoh, Carl ^a   Herschman, Harvey ^f   Karin, Michael ^a   Kipps, Thomas J ^a  

^a School of Medicine   (Netherlands)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e UNIVERSITY OF IOWA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

I B kinase inhibitor; Leukemia cell survival; Nuclear factor light chain enhancer of activated B cells; Nurselike cells; Prognostic factors

Indexed keywords

B CELL ACTIVATING FACTOR; CD5 ANTIGEN; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; B CELL LEUKEMIA; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENDER BIAS; HUMAN; HUMAN CELL; MALE; MOUSE; MYELOID LEUKEMIA; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; VIRUS ONCOGENE;

MUS;

EID: 78650481186     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1013420107     Document Type: Article

References (28)

1. Taub R, et al. (1982) Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci USA 79:7837-7841.
2. Ladanyi M, Offit K, Jhanwar SC, Filippa DA, Chaganti RS (1991) MYC rearrangement and translocations involving band 8q24 in diffuse large cell lymphomas. Blood 77: 1057-1063.
3. Avet-Loiseau H, et al.; Intergroupe Francophone du Myélome (2001) Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors. Blood 98:3082-3086.
4. Huh YO, et al. (2008) MYC translocation in chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosis. Br J Haematol 142: 36-44.
5. Adams JM, et al. (1985) The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318:533-538.
6. Janz S (2006) Myc translocations in B cell and plasma cell neoplasms. DNA Repair (Amst) 5:1213-1224.
7. Cheung WC, et al. (2004) Novel targeted deregulation of c-Myc cooperates with Bcl-X (L) to cause plasma cell neoplasms in mice. J Clin Invest 113:1763-1773.
8. Endo T, et al. (2007) BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway. Blood 109:703-710.
9. Mackay F, et al. (1999) Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 190:1697-1710.
10. Enzler T, et al. (2006) Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease. Immunity 25:403-415.
11. Khare SD, et al. (2000) Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc Natl Acad Sci USA 97:3370-3375.
12. Enzler T, et al. (2009) Chronic lymphocytic leukemia of Emu-TCL1 transgenic mice undergoes rapid cell turnover that can be offset by extrinsic CD257 to accelerate disease progression. Blood 114:4469-4476.
13. Klein U, et al. (2001) Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med 194: 1625-1638.
14. Damle RN, et al. (2002) B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood 99: 4087-4093.
15. Bruzzi JF, et al. (2006) Detection of Richter's transformation of chronic lymphocytic leukemia by PET/CT. J Nucl Med 47:1267-1273.
16. Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov JP (2007) GSEA-P: A desktop application for Gene Set Enrichment Analysis. Bioinformatics 23:3251-3253.
17. Obermann EC, et al. (2007) Cell cycle phase distribution analysis in chronic lymphocytic leukaemia: A significant number of cells reside in early G1-phase. J Clin Pathol 60:794-797.
18. Rassenti LZ, et al. (2004) ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 351:893-901.
19. Nishio M, et al. (2005) Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha. Blood 106:1012-1020.
20. Tsukada N, Burger JA, Zvaifler NJ, Kipps TJ (2002) Distinctive features of "nurselike" cells that differentiate in the context of chronic lymphocytic leukemia. Blood 99: 1030-1037.
21. Yan M, et al. (2001) Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency. Curr Biol 11:1547-1552.
22. Bichi R, et al. (2002) Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci USA 99:6955-6960.
23. Zapata JM, Krajewska M, Morse HC, 3rd, Choi Y, Reed JC (2004) TNF receptorassociated factor (TRAF) domain and Bcl-2 cooperate to induce small B cell lymphoma/chronic lymphocytic leukemia in transgenic mice. Proc Natl Acad Sci USA 101: 16600-16605.
24. He B, et al. (2004) Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL. J Immunol 172:3268-3279.
25. Sachdeva M, et al. (2009) p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci USA 106:3207-3212.
26. Bojarska-Junak A, et al. (2009) BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: Correlation with biological and clinical features. Leuk Res 33:1319-1327.
27. Schmid C, Isaacson PG (1994) Proliferation centres in B-cell malignant lymphoma, lymphocytic (B-CLL): An immunophenotypic study. Histopathology 24:445-451.
28. Burger JA, Ghia P, Rosenwald A, Caligaris-Cappio F (2009) The microenvironment in mature B-cell malignancies: A target for new treatment strategies. Blood 114: 3367-3375